CytoMed Therapeutics Limited (GDTC)

NASDAQ: GDTC · Real-Time Price · USD

1.290

+0.110 (9.32%)

At close: Jun 5, 2026, 4:00 PM EDT

1.200

-0.090 (-6.98%)

After-hours: Jun 5, 2026, 6:19 PM EDT

Revenue by Segment

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Immune Cell Therapy	860.85K	503.37K	507.74K	1.00	113.84K
Immune Cell Therapy Growth	71.02%	-0.86%	50773500.00%	-100.00%	91.43%
Total	860.85K	503.37K	507.74K	1.00	113.84K
Total Growth	71.02%	-0.86%	50773500.00%	-100.00%	91.43%

Source: S&P Global Market Intelligence.